Semi-Annual Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7262351

Concept 2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
Semi-annual consolidated statement of income
Statement of income
Net sales
102,618,000,000 JPY
156,006,000,000 JPY
141,706,000,000 JPY
96,647,000,000 JPY
Cost of sales
44,957,000,000 JPY
64,810,000,000 JPY
62,735,000,000 JPY
44,733,000,000 JPY
Gross profit (loss)
57,661,000,000 JPY
91,196,000,000 JPY
78,970,000,000 JPY
51,914,000,000 JPY
Ordinary profit (loss)
16,511,000,000 JPY
24,010,000,000 JPY
19,649,000,000 JPY
14,226,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
14,582,000,000 JPY
15,327,000,000 JPY
Salaries
4,821,000,000 JPY
4,726,000,000 JPY
Bonuses
1,354,000,000 JPY
1,412,000,000 JPY
Taxes and dues
572,000,000 JPY
441,000,000 JPY
Depreciation
1,317,000,000 JPY
973,000,000 JPY
Selling, general and administrative expenses
43,953,000,000 JPY
72,300,000,000 JPY
65,803,000,000 JPY
41,210,000,000 JPY
Extraordinary income
5,044,000,000 JPY
5,044,000,000 JPY
391,000,000 JPY
391,000,000 JPY
Extraordinary losses
365,000,000 JPY
367,000,000 JPY
854,000,000 JPY
852,000,000 JPY
Profit (loss) before income taxes
21,190,000,000 JPY
28,687,000,000 JPY
19,186,000,000 JPY
13,765,000,000 JPY
Operating profit (loss)
13,707,000,000 JPY
18,895,000,000 JPY
13,167,000,000 JPY
10,704,000,000 JPY
Income taxes - current
3,917,000,000 JPY
5,624,000,000 JPY
3,903,000,000 JPY
2,580,000,000 JPY
Non-operating income
Interest income
73,000,000 JPY
2,748,000,000 JPY
2,564,000,000 JPY
55,000,000 JPY
Dividend income
2,003,000,000 JPY
1,245,000,000 JPY
1,120,000,000 JPY
1,554,000,000 JPY
Share of profit of entities accounted for using equity method
590,000,000 JPY
585,000,000 JPY
Non-operating income
2,890,000,000 JPY
5,365,000,000 JPY
6,605,000,000 JPY
3,601,000,000 JPY
Income taxes - deferred
908,000,000 JPY
760,000,000 JPY
851,000,000 JPY
1,329,000,000 JPY
Non-operating expenses
Interest expenses
23,000,000 JPY
18,000,000 JPY
Non-operating expenses
85,000,000 JPY
251,000,000 JPY
123,000,000 JPY
80,000,000 JPY
Income taxes
4,826,000,000 JPY
6,385,000,000 JPY
4,754,000,000 JPY
3,910,000,000 JPY
Profit (loss)
16,363,000,000 JPY
22,301,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
14,431,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
Extraordinary income
Profit (loss) attributable to non-controlling interests
543,000,000 JPY
461,000,000 JPY
Extraordinary losses
Impairment losses
343,000,000 JPY
343,000,000 JPY
847,000,000 JPY
847,000,000 JPY
Profit (loss) attributable to owners of parent
21,758,000,000 JPY
21,758,000,000 JPY
21,758,000,000 JPY
13,969,000,000 JPY
13,969,000,000 JPY
13,969,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-3,580,000,000 JPY
4,887,000,000 JPY
Foreign currency translation adjustment
9,764,000,000 JPY
5,874,000,000 JPY
Remeasurements of defined benefit plans, net of tax
1,039,000,000 JPY
428,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
21,000,000 JPY
104,000,000 JPY
Other comprehensive income
7,244,000,000 JPY
11,295,000,000 JPY
Comprehensive income
29,546,000,000 JPY
25,727,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
28,954,000,000 JPY
25,193,000,000 JPY
Comprehensive income attributable to non-controlling interests
592,000,000 JPY
533,000,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.